Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

Total article views   Abstract views HTML views PDF downloads Totals
730 Dovepress* 730 0+ 93 730
Totals 730 0 93 730
*Since 22 April 2021
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on Google Scholar